NeoGenesis Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

NeoGenesis Pharmaceuticals Ownership

Who owns NeoGenesis Pharmaceuticals?

NeoGenesis Pharmaceuticals is owned by Schering-Plough. It was acquired on February 14, 2005.

NeoGenesis Pharmaceuticals Business Overview

Where is NeoGenesis Pharmaceuticals headquartered?

NeoGenesis Pharmaceuticals is headquartered in Cambridge, Massachusetts.

How many employees does NeoGenesis Pharmaceuticals have?

NeoGenesis Pharmaceuticals has 90 employees.

What sector is NeoGenesis Pharmaceuticals in?

NeoGenesis Pharmaceuticals is a life science company.

When was NeoGenesis Pharmaceuticals founded?

NeoGenesis Pharmaceuticals was founded in 1997.

Life Science M&A Summary in 2005

Out of 60 sectors in the Mergr database, life science ranked 14 in number of deals in 2005. The largest life science acquisition in 2005 was Ivax - which was acquired by Teva Pharmaceutical Industries for $7.4B.

Join Mergr to view all 77 acquisitions of life science companies in 2005, including 17 acquisitions by private equity firms, and 60 by strategics.

NeoGenesis Pharmaceuticals, Inc.

540 Memorial Drive,
Cambridge, Massachusetts 02139
United States,
(617) 868-1500

NeoGenesis Pharmaceuticals, Inc. is a biopharmaceutical company focused on applying novel screening and chemistry technologies to discover and develop small molecule drugs.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.